PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
29-Apr-2021 Nemysis Ltd Announces Appointment of Dr. Margit Holzer to Its Scientific Advisory Board Newswire
28-Apr-2021 Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year Takeda
28-Apr-2021 WholisticResearch Acquires Domain of Adherex Technologies Inc. Newswire
28-Apr-2021 GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals Newswire
27-Apr-2021 Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability Newswire
27-Apr-2021 Enalare Therapeutics Announces Partnership With BARDA to Advance Development of Its Lead Product ENA-001 Newswire
26-Apr-2021 GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel Newswire
23-Apr-2021 Newswire's Medical Technology Client Shares Insights on Chronic Pain Treatment During Interview with Popular NBC Affiliate Station Newswire
23-Apr-2021 Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti Newswire
23-Apr-2021 Registration Opens for SMi's Aseptic Processing Conference 2021 SMi Group
20-Apr-2021 eDeviation the New Protocol Deviations Cloud Software Solution Newswire
16-Apr-2021 BenchSci Ranks 26 on the 2021 List of 50 Best Workplaces in Canada Newswire
16-Apr-2021 Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients. Clinerion Ltd.
15-Apr-2021 Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference SMi Group
15-Apr-2021 Investigation Report on the Chinese Cefoperazone Sodium and Sulbactam Sodium Markets, 2016-2020 & 2021-2025 - ResearchAndMarkets.com Businesswire
15-Apr-2021 Qlaris Bio Enrolls First Patient in Phase 1/2 Studies of QLS-101, an Investigational Therapy Designed to Lower Episcleral Venous Pressure (EVP) in Patients with Glaucoma Businesswire
15-Apr-2021 Inflammatix Appoints Amy Boyle as Chief Operating Officer Businesswire
15-Apr-2021 Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration Businesswire
15-Apr-2021 Global Pharma, Biotech and Diagnostics Joint Venture Partnering Terms and Agreements Directory 2014-2021: Company A-Z, Headline Value, Therapeutic Area, & Technology Type - ResearchAndMarkets.com Businesswire
15-Apr-2021 Peter Windisch zum Chief Technology Officer von Excelya berufen Businesswire